Blockchain Registration Transaction Record

Earth Science Tech (ETST) Leverages Telehealth and Peptide Therapies for Growth

Earth Science Tech (ETST) is capitalizing on telehealth and peptide therapy growth with proprietary tech. Learn how its subsidiaries drive innovation in a $249B market.

This news matters because Earth Science Tech is strategically positioning itself in two high-growth sectors—telehealth and peptide therapies—that are reshaping healthcare delivery and treatment. As telehealth becomes a standard care model and peptide therapies gain traction for their clinical effectiveness, ETST’s investments in subsidiaries like DOConsultations and Las Villas Health Care could drive significant value. For investors and patients alike, this signals a shift toward more accessible, technology-driven healthcare solutions that may improve outcomes and reduce costs. Understanding ETST’s vertical integration and proprietary tech gives insight into which companies are leading this transformation.